sinc
discoveri
late
earli
modif
ubiquitin
target
protein
degrad
proteasom
system
up
emerg
essenti
regul
almost
cellular
process
eukaryot
asid
maintain
proteostasi
degrad
damag
unwant
protein
ubiquitin
subsequ
degrad
regul
activ
mani
protein
includ
cell
cycl
regul
transcript
factor
produc
antigen
peptid
present
cell
surfac
ubiquitin
also
mani
role
includ
regul
dna
damag
repair
receptor
endocytosi
inflamm
surprisingli
dysregul
up
contribut
mani
ill
includ
cancer
neurodegen
diseas
immunolog
disord
ubiquitin
ub
small
kda
globular
protein
amino
acid
adopt
fold
fig
highli
conserv
found
eukaryot
ub
attach
substrat
termin
glycin
residu
process
refer
ubiquitin
ubiquityl
typic
ub
attach
protein
via
isopeptid
bond
lysin
side
chain
protein
may
also
ubiquitin
n
terminu
via
peptid
bond
ub
ubiquitin
polyubiquitin
give
rise
ub
chain
occur
one
seven
ly
residu
met
residu
polyubiquitin
modif
target
protein
proteasom
degrad
chain
type
typic
signal
role
exampl
also
call
linear
chain
import
sever
immun
signal
pathway
ubiquitin
archetyp
exampl
group
protein
refer
protein
ubl
human
includ
sumo
small
modifi
famili
protein
neural
precursor
cell
express
development
sever
homolog
yeast
protein
differ
conjug
deconjug
machineri
exist
ubl
although
appear
consider
overlap
enzym
function
sever
class
ubl
prokaryot
encod
ub
produc
small
protein
modifi
attach
enzymat
target
protein
function
modifi
fulli
understood
instanc
prokaryot
protein
pup
mycobacterium
tuberculosi
direct
protein
proteasom
degrad
ubiquitin
dynam
modif
dedic
system
enzym
respons
transfer
ub
substrat
proteas
respons
remov
ub
conjug
requir
sequenti
action
three
class
enzym
fig
enzym
initi
activ
free
ubiquitin
mechan
first
step
enzym
bind
ub
atp
catalyz
ub
form
ubamp
tild
use
indic
reactiv
coval
bond
colon
indic
noncoval
complex
second
step
ub
transfer
onto
cy
residu
form
thioether
linkag
activ
ub
next
transfer
cy
residu
sometim
refer
enzym
give
togeth
ub
ligas
transfer
ub
substrat
confer
substrat
specifi
enzym
ligas
largest
group
form
coval
bond
ub
howev
two
smaller
group
hect
ligas
member
rbr
ligas
member
accept
ub
form
transfer
ub
substrat
deubiquitinas
dub
proteas
hydrolyz
amid
bond
gli
residu
ub
ubiquitin
protein
therebi
antagon
ub
conjug
machineri
well
rescu
protein
degrad
revers
signal
event
induc
ubiquitin
certain
dub
cleav
ub
gene
product
individu
ub
monom
prior
activ
proteasom
regulatori
particl
also
contain
three
dub
recycl
ub
remov
protein
prior
degrad
locat
close
entranc
core
promot
substrat
degrad
cleav
entir
ub
chain
substrat
allow
protein
enter
pore
degrad
contrast
locat
core
antagon
degrad
remov
ub
stepwis
manner
distal
end
promot
substrat
dissoci
proteasom
human
genom
encod
approxim
dub
fall
six
class
five
class
cy
proteas
proteas
usp
ubiquitin
hydrolas
uch
ovarian
tumor
domain
proteas
otu
diseas
domain
proteas
mjd
josephin
motif
interact
novel
dub
famili
mindi
dub
sixth
class
dub
jamm
also
known
mpn
metalloproteas
enzym
attach
remov
ub
attract
signific
interest
therapeut
target
inhibitor
pevonedistat
phase
ii
trial
leukemia
clinicaltrialsgov
identifi
ub
inhibitor
also
recent
enter
clinic
trial
clinicaltrialsgov
identifi
immunomodulatori
imid
drug
imid
thalidomid
known
target
cereblon
approv
hematolog
malign
sever
class
compound
target
ub
ligas
clinic
trial
compound
antagon
interact
substrat
tumor
suppressor
therebi
increas
stabil
antagonist
inhibitor
apoptosi
iap
famili
protein
also
enter
clinic
trial
recent
dub
inhibitor
enter
phase
trial
multipl
myeloma
clinicaltrialsgov
identifi
tool
studi
activ
ub
conjug
deconjug
machineri
therefor
valuabl
better
understand
function
enzym
also
identifi
character
new
inhibitor
enzym
activ
tightli
control
level
allow
cell
respond
rapidli
stimuli
avoid
unwant
activ
enzymat
activ
mani
proteas
secret
inact
form
must
undergo
activ
either
irrevers
eg
proteolysi
revers
eg
phosphoryl
format
complex
protein
ph
chang
chang
local
protein
express
indic
western
blot
proteom
techniqu
therefor
use
reliabl
infer
enzym
activ
turnov
natur
substrat
provid
direct
measur
activ
requir
detect
reaction
product
may
challeng
complex
cellular
environ
addit
differ
enzym
often
process
substrat
make
difficult
assign
activ
particular
enzym
probe
abp
mimic
substrat
rather
process
enzym
becom
coval
attach
activ
site
reaction
abp
react
inact
enzym
extent
probe
label
indirect
measur
enzym
activ
abp
particularli
well
suit
studi
enzym
nucleophil
catalyt
residu
reactiv
electrophil
incorpor
probe
react
coval
nucleophil
consequ
cystein
threonin
serin
proteas
extens
studi
abp
abp
consist
three
three
rs
fig
reactiv
group
enzym
activ
site
nucleophil
electrophil
often
refer
warhead
choic
reactiv
group
affect
reactiv
select
probea
recognit
element
target
group
confer
select
toward
target
interest
may
inhibitor
short
peptid
proteina
report
tag
also
refer
handl
label
detect
protein
fluorophor
facilit
rapid
sensit
detect
affin
label
biotin
peptid
epitop
also
allow
isol
enrich
label
protein
altern
small
bioorthogon
group
alkyn
azid
may
includ
probe
allow
subsequ
attach
report
often
refer
label
may
particularli
advantag
larger
tag
interfer
reactiv
select
physiochem
properti
probe
larg
abp
particularli
dub
probe
describ
substanti
increas
molecular
weight
target
protein
mass
shift
sdspage
gel
use
indic
probe
label
probe
differ
probe
lack
reactiv
group
becom
coval
attach
activ
site
fluorogen
substrat
frequent
use
proteas
probe
turn
enzym
use
kinet
studi
howev
difficult
assign
substrat
turnov
activ
particular
proteas
abp
overcom
limit
form
coval
bond
target
enzym
therefor
power
tool
identifi
isol
label
proteas
major
advantag
studi
enzym
famili
overlap
substrat
select
dub
detail
comparison
probe
present
recent
review
abp
use
studi
activ
mani
member
protein
class
simultan
techniqu
refer
protein
profil
abpp
ub
conjug
deconjug
machineri
uniqu
suit
studi
use
abp
due
preval
enzym
activ
site
nucleophil
dub
cy
proteas
abp
bear
electrophil
proven
power
tool
identifi
dub
studi
activ
select
dub
inhibitor
character
dub
enzymat
activ
determin
physiolog
role
proteas
famili
addit
enzym
employ
catalyt
cy
residu
transfer
ub
recent
exploit
develop
abp
review
focu
design
applic
abp
dub
also
discuss
recent
develop
abp
machineri
enzym
although
enzym
proteas
probe
share
mani
similar
featur
dub
abp
first
abp
develop
dub
contain
singl
ubiquitin
electrophil
place
gli
residu
ubal
import
tool
earli
mechanist
studi
dub
notabl
use
demonstr
ubiquitin
hydrolas
form
coval
intermedi
catalysi
ubal
also
use
solv
first
structur
dub
complex
ub
reveal
conform
chang
associ
ub
bind
howev
modif
dub
ubal
revers
compat
strongli
reduc
condit
sdspage
overcom
limit
probe
borodovski
et
al
develop
first
irrevers
dub
abp
introduc
vinyl
methyl
sulfon
vs
probe
label
dub
cell
lysat
could
detect
follow
sdspage
due
presenc
ha
tag
probe
relat
probe
gabarap
report
shortli
thereaft
wide
rang
electrophil
sinc
investig
summar
tabl
electrophil
classifi
accord
natur
reaction
catalyt
cy
fig
vinyl
methyl
sulfon
vinyl
methyl
ester
vme
wide
employ
show
slightli
greater
reactiv
propargyl
amid
also
react
dub
activ
site
cy
residu
form
vinyl
thioether
surpris
reaction
appear
proceed
via
direct
nucleophil
attack
intern
alkyn
carbon
facilit
stabil
develop
carbanion
oxyanion
hole
activ
site
result
adduct
stabl
denatur
reduc
condit
could
cleav
acid
use
proteom
studi
conjug
form
abp
discuss
note
conjug
addit
electrophil
vs
vme
principl
revers
basic
condit
appear
occur
condit
probe
use
probe
react
catalyt
cy
nucleophil
substitut
use
wide
although
varieti
leav
group
investig
alkyl
halid
label
distinct
though
restrict
subset
dub
compar
vsvme
electrophil
import
identif
otu
dub
discuss
acyloxymethyl
keton
aomk
reactiv
vsvme
electrophil
show
similar
activ
lysat
perhap
due
instabl
consist
high
reactiv
toward
cy
nucleophil
aomk
label
mani
enzym
addit
dub
conjug
react
cy
residu
mani
protein
molecul
truli
regard
abp
say
target
activ
dub
label
dub
regardless
whether
enzym
catalyt
activ
form
sever
instanc
dub
reactiv
toward
probe
shown
chang
stimulu
without
chang
dub
express
suggest
probe
inde
target
activ
subpopul
enzym
exampl
treat
cell
hydrogen
peroxid
reduc
label
dub
due
oxid
catalyt
cy
residu
revealingli
studi
naik
dixit
show
catalyt
activ
activ
phosphoryl
upon
receptor
activ
brief
stimul
cell
increas
label
without
increas
level
mutant
still
possess
potenti
reactiv
activ
site
cy
residu
much
less
reactiv
toward
probe
follow
stimul
henc
probe
distinguish
activ
inact
form
probe
label
could
also
give
mislead
indic
activ
reaction
occur
noncatalyt
residu
case
react
preferenti
noncatalyt
cy
probe
label
indic
deubiquitin
activ
clear
widespread
phenomenon
therefor
interpret
experi
use
conjug
research
awar
possibl
label
aris
electrophil
natur
probe
protein
label
conjug
perhap
best
refer
rather
activ
radioiodin
nonspecif
biotinyl
probe
initi
use
detect
protein
howev
prepar
label
probe
technic
challeng
give
inhomogen
label
furthermor
radiolabel
allow
retriev
identif
protein
techniqu
supplant
use
epitop
tag
ha
tag
wide
use
littl
effect
ub
recognit
epitop
tag
use
success
exampl
use
abp
identifi
deneddylas
insolubl
epitop
tag
facilit
detect
isol
label
protein
analysi
dub
lysat
detect
tag
western
blot
allow
rapid
visual
dub
activ
howev
relat
pattern
seen
blot
activ
individu
dub
protein
label
specif
band
must
identifi
usual
tandem
ms
addit
resolut
protein
techniqu
poor
one
appar
label
protein
gel
may
contain
mani
label
dub
studi
activ
specif
dub
investig
frequent
take
advantag
kda
increas
mw
probe
label
blot
individu
dub
compar
intens
larger
label
band
smaller
unlabel
band
reactiv
dub
toward
probe
infer
affin
purif
employ
epitop
tag
use
enrich
label
protein
facilit
detect
identif
dub
purifi
dub
digest
solut
identifi
tandem
ms
initi
resolv
sdspage
follow
digest
ms
identif
digest
procedur
advantag
improv
quantit
detect
protein
requir
complex
analysi
review
ms
proteom
techniqu
up
research
publish
recent
develop
peptid
synthesi
protein
chemistri
allow
incorpor
rang
label
c
n
termini
mcgouran
et
al
introduc
probe
contain
fluorophor
fluorescein
c
terminu
fluoresc
gave
better
resolut
label
protein
immunoblot
particularli
high
mw
protein
transfer
step
necessari
prior
visual
probe
somewhat
less
reactiv
unmodifi
attribut
size
charg
fluorophor
posit
close
dub
activ
site
contrast
probe
fluorophor
report
de
jong
et
al
show
activ
toward
dub
unmodifi
conjug
prepar
total
chemic
synthesi
allow
great
flexibl
choic
modif
varieti
dye
tmr
affin
tag
ha
biotin
linker
aminohexano
acid
lysin
photocleav
linker
could
incorpor
method
addit
probe
prepar
exampl
contain
biotin
affin
purif
label
dub
fluoresc
imag
claessen
et
al
devis
altern
strategi
function
use
sortag
ie
ligat
appropri
tag
proteinpeptid
fragment
introduc
biotin
label
addit
incorpor
chemic
cleavabl
linker
biotin
ub
n
terminu
linker
allow
elut
ms
identif
protein
affin
purif
dub
must
bind
ub
close
catalyt
activ
site
therefor
employ
recognit
element
abp
target
mani
dub
even
dub
prefer
substrat
ubiquitin
necessari
effect
reaction
probe
dub
contrast
abp
mani
proteas
short
peptid
recognit
element
requir
requir
ubiquitin
result
sever
factor
catalyt
domain
dub
contain
larg
surfac
mani
interact
therefor
contribut
affin
dub
ub
difficult
mimic
small
recognit
element
short
channel
lead
surfac
activ
site
provid
select
tail
ub
ubl
contribut
weakli
bind
ub
core
tail
requir
bind
ub
peptid
ub
truncat
mutant
lack
motif
show
neglig
bind
catalyt
domain
structur
rearrang
dub
catalyt
domain
occur
upon
ub
bind
mani
apo
dub
catalyt
domain
catalyt
inact
conform
would
unreact
toward
abp
ub
bind
bring
activ
site
residu
correct
align
catalysi
occur
caus
transloc
surfac
loop
otherwis
block
activ
site
seem
borodovski
et
al
investig
ub
ubl
peptid
recognit
element
abp
synthes
rang
peptid
vari
length
base
c
termini
ubl
label
lysat
could
inhibit
preincub
high
concentr
peptid
base
ub
c
terminu
shorter
sequenc
ineffect
contrast
short
recognit
element
may
suitabl
probe
senp
proteas
remov
molecul
sumo
protein
immedi
appar
senp
probe
would
requir
much
shorter
recognit
element
dub
probe
borodovski
et
al
note
senp
recogn
smaller
surfac
area
substrat
catalyt
site
compar
dub
henc
may
abl
bind
shorter
peptid
sequenc
deubiquitinaseubl
proteas
ulp
abp
gener
due
larg
recognit
element
probe
treatment
must
therefor
carri
cell
lysat
prefer
dub
would
label
nativ
cellular
environ
disrupt
subcellular
local
weak
interact
factor
may
affect
dub
activ
toxin
electropor
use
deliv
probe
cell
subsequ
abpp
experi
success
case
clear
whether
techniqu
sensit
label
lysat
shorter
recognit
element
may
improv
cell
permeabl
disappointingli
small
peptid
inhibitor
senp
appear
ward
et
al
recent
describ
first
dub
abp
screen
dub
inhibitor
identifi
inhibitor
usp
activ
convert
abp
author
prepar
analog
tabl
competit
abpp
intact
cell
pretreat
vari
concentr
untag
inhibitor
follow
label
nm
probe
use
identifi
specif
probe
target
twelv
usp
identifi
nine
could
compet
away
excess
unlabel
probe
probe
also
label
sever
recombin
usp
express
cell
howev
probe
target
mani
protein
presum
nonspecif
reaction
reactiv
cy
residu
abp
describ
reli
sole
interact
ub
site
bind
ub
distal
scissil
bond
affin
specif
dub
notabl
uch
famili
prefer
process
ub
short
extens
dub
cleav
ub
ubiquitin
substrat
substrat
may
ubiquitin
protein
dub
display
specif
posit
ub
chain
exo
endo
base
cleavag
linkag
type
use
addit
site
recogn
ub
distal
side
site
proxim
side
site
fig
apb
therefor
develop
order
studi
activ
linkag
specifi
dub
tabl
summar
probe
report
date
along
linkag
type
studi
probe
type
first
abp
report
et
al
use
short
peptid
conjug
ly
isopeptid
bond
mimic
proxim
ub
structur
tabl
probe
mimick
show
expect
reactiv
toward
small
number
recombin
dub
label
differ
set
dub
lysat
determin
abpp
experi
appar
structur
studi
howev
dub
make
extens
contact
proxim
ub
site
probe
contain
short
peptid
therefor
unlik
recapitul
reactiv
select
subsequ
effort
therefor
focus
make
probe
contain
two
intact
ub
monom
sever
group
recent
report
strategi
make
probe
either
semisynthesi
use
recombin
protein
structur
tabl
total
chemic
synthesi
structur
tabl
gener
probe
show
expect
reactiv
toward
dub
known
linkag
select
exampl
gener
unselect
usp
dub
react
probe
dub
react
preferenti
probe
activ
probe
verifi
lysat
appear
probe
effect
mimic
chain
link
via
ub
ly
residu
prove
challeng
develop
probe
mimick
linear
ub
linkag
employ
mcgouran
et
al
structur
tabl
design
mimic
isopeptid
linkag
significantli
longer
flexibl
nativ
peptid
linkag
react
known
dub
otulin
react
show
littl
activ
toward
chain
vitro
probe
report
et
al
structur
tabl
cleav
dub
otulin
rather
react
coval
electrophil
dehydroalanin
site
appear
inaccess
catalyt
cy
probe
proven
invalu
tool
identifi
new
dub
ulp
varieti
organ
one
earliest
applic
abp
identifi
dub
borodovski
et
al
use
label
dub
yeast
human
cell
lysat
author
compar
label
mutant
lack
put
dub
identifi
label
proteas
comparison
label
human
cell
led
identif
homolog
yeast
dub
howev
approach
identifi
dub
cumbersom
requir
prior
knowledg
candid
protein
combin
tandem
mass
spectrometri
protein
identif
tag
probe
enrich
label
protein
allow
dub
identifi
high
sensit
unbias
manner
notabl
abp
use
identifi
otu
famili
dub
abp
also
wide
use
identifi
dub
pathogen
organ
includ
virus
adenovirida
herpesvirida
bacteria
chlamydia
trachomati
legionella
pneumophilia
escherichia
coli
parasit
protozoa
toxoplasma
gondii
plasmodium
falciparum
nematod
trichinella
spirali
prokaryot
virus
unlik
eukaryot
pathogen
lack
ubiquitin
machineri
therefor
pathogen
probabl
evolv
function
order
hijack
host
up
although
appar
dub
may
prefer
pathogen
substrat
happen
share
similar
ububl
conjug
recent
studi
pruneda
et
al
examin
deubiquitin
activ
multipl
bacteri
proteas
use
combin
abp
fluoresc
substrat
author
verifi
deubiquitinas
andor
deneddylas
activ
sever
previous
propos
bacteri
dub
identifi
three
novel
enzym
rickettsia
bellii
shigella
flexneri
xanthomona
campestri
notabl
bacteri
dub
belong
ce
proteas
clan
human
limit
deneddylas
desumoylas
bacteri
member
ce
clan
also
act
acetyltransferas
appear
singl
catalyt
fold
evolv
differ
organ
perform
remark
divers
function
use
abp
examin
dub
select
becom
possibl
sinc
develop
abp
mcgouran
et
al
profil
dub
activ
cell
lysat
tandem
ms
panel
probe
differ
geometri
nativ
isopeptid
linkag
triazol
linkag
employ
probe
structur
tabl
may
alter
reactiv
comprehens
abpp
experi
newer
probe
yet
report
sever
recent
exampl
highlight
potenti
abp
studi
linkag
select
dub
studi
substrat
select
use
recent
abp
intern
electrophil
structur
tabl
substrat
allow
analysi
prefer
provid
inform
effect
site
fig
flierman
et
al
use
abp
termin
electrophil
structur
tabl
combin
substrat
probe
termin
fluorophor
studi
effect
site
observ
signific
differ
select
otu
dub
exampl
fairli
promiscu
cleav
substrat
show
prefer
termin
abp
suggest
pocket
refin
select
dub
toward
chain
cleav
react
probe
kinet
studi
use
substrat
probe
suggest
select
longer
chain
driven
affin
lower
km
appear
driven
vmax
hint
bind
chain
may
optim
reorgan
activ
site
catalysi
author
note
differ
select
across
site
suggest
prefer
endogen
substrat
dub
may
heterotyp
chain
test
hypothesi
requir
develop
reagent
mix
linkag
type
similar
influenc
prefer
observ
proteas
sever
acut
respiratori
syndrom
coronaviru
sar
plpro
enzym
known
cleav
polyubiquitin
chain
minim
prefer
substrat
three
ub
unit
lead
accumul
explor
strike
select
et
al
compar
reactiv
enzym
toward
probe
either
intern
structur
tabl
distal
electrophil
structur
tabl
probe
enzym
react
rapidli
distal
probe
slowli
slowli
intern
probe
led
author
conclud
sar
plpro
recogn
linkag
two
distal
ub
cleav
specif
across
much
weaker
across
distal
probe
subsequ
use
structur
studi
understand
sar
plpro
bind
taken
togeth
studi
highlight
valu
use
abp
combin
tool
includ
substrat
probe
studi
complex
dub
select
deubiquitinas
abp
use
identifi
chang
dub
activ
differ
condit
differ
cell
type
first
studi
employ
dub
apb
profil
dub
activ
tumor
normal
cell
pair
normal
tumor
biopsi
cervic
carcinoma
patient
howev
identifi
consist
chang
pattern
dub
activ
challeng
biolog
signific
observ
differ
unclear
studi
taken
focus
approach
appli
stimulu
cell
monitor
chang
dub
activ
identifi
dub
larg
chang
activ
valid
role
system
interest
notabl
exampl
strategi
identif
regul
adipogenesi
use
monitor
chang
dub
activ
vitro
adipogenesi
model
identifi
substanti
increas
activ
experi
confirm
requir
adipogenesi
exert
effect
deubiquitni
stabil
acetyltransferas
key
regul
adipocyt
differenti
approach
also
use
studi
effect
infect
host
dub
kummari
et
al
use
profil
dub
activ
chicken
macrophag
identifi
sever
dub
chang
substanti
activ
follow
infect
activ
decreas
although
protein
level
remain
similar
dub
increas
activ
protein
level
author
went
demonstr
express
increas
secret
increas
level
key
member
inflammasom
process
activ
form
studi
other
point
toward
role
dub
innat
immun
respons
bacteri
infect
modul
inflammasom
format
cytokin
section
pyroptosi
molecular
mechan
underli
possibl
role
inflammasom
regul
includ
target
deubiquitinas
activ
yet
unclear
studi
highlight
demonstr
potenti
abpp
identifi
dub
involv
cellular
process
exemplifi
differenti
innat
immun
respons
abpp
offer
altern
approach
function
genom
techniqu
overexpress
sirna
screen
dub
notabl
overexpress
screen
also
identifi
deubiquitinas
identifi
dub
involv
inflammasom
format
abpp
measur
endogen
dub
activ
avoid
problem
introduc
artifici
overexpress
reduc
gene
express
chang
viabil
effect
abpp
also
advantag
experiment
simplic
transfect
requir
dub
activ
measur
singl
experi
either
assay
tandem
ms
howev
activ
mani
dub
may
chang
experiment
control
condit
identifi
function
relev
challeng
addit
abp
equal
reactiv
toward
dub
chang
activ
dub
unreact
toward
probe
metalloproteas
jammmpn
famili
miss
protein
profil
wide
use
assess
inhibitor
select
typic
experi
often
refer
competit
abpp
cell
incub
compound
interest
lyse
treat
apb
compound
treatment
also
perform
use
lysat
comparison
untreat
control
indic
level
inhibit
experi
profil
dub
activ
cell
method
provid
rapid
readout
approach
best
semiquantit
identifi
compound
target
challeng
quantit
ms
overcom
limit
expens
experiment
simplic
notabl
abpp
use
assess
select
develop
dub
inhibitor
far
progress
clinic
trial
hit
compound
initi
identifi
induc
lysosom
apoptosi
pathway
subsequ
shown
inhibit
proteasom
analysi
label
show
littl
global
effect
compound
dub
activ
label
isol
proteasom
regulatori
particl
inhibit
regulatori
particl
contain
two
dub
inhibit
compound
slightli
greater
inhibitori
activ
toward
show
similar
select
toward
find
confirm
convent
inhibit
assay
use
recombin
dub
fluorogen
substrat
presum
believ
revers
inhibitor
proteasom
dub
nonetheless
abl
inhibit
label
irrevers
probe
note
revers
irrevers
inhibitor
behav
quit
differ
competit
abpp
experi
degre
inhibit
irrevers
inhibitor
sensit
time
inhibitor
treatment
label
revers
inhibitor
affect
chang
concentr
inhibitor
treatment
label
detail
discuss
dub
inhibitor
select
sever
recent
review
avail
prior
develop
abp
enzym
tool
design
use
structur
studi
captur
coval
intermedi
reaction
mechan
close
parallel
use
ubal
obtain
dub
structur
prior
develop
dub
abp
eleg
studi
olsen
et
al
develop
sumoamp
mimic
trap
tetrahedr
intermedi
form
catalyt
cy
residu
fig
compound
linkag
replac
vinyl
sulfonamid
also
develop
unreact
sumoamp
mimic
incorpor
unreact
structur
sumo
bound
two
compound
reveal
major
differ
protein
architectur
initi
complex
adopt
open
conform
activ
site
organ
atp
bind
catalyt
cy
buri
far
sumo
adenyl
contrast
coval
complex
adopt
close
conform
radic
differ
activ
site
residu
involv
catalyz
first
step
swap
requir
transesterif
reaction
therefor
enzym
appear
two
spatial
distinct
activ
site
rather
region
around
sumo
c
terminu
amp
remodel
adenyl
reaction
order
catalyz
transesterif
synthet
sumo
adenyl
mimic
vital
crystal
enzym
otherwis
transient
state
illumin
complex
dynam
enzym
catalysi
similar
probe
also
react
inhibit
ub
enzym
despit
util
trap
tetrahedr
intermedi
complex
sever
drawback
broadli
applic
abp
includ
lengthi
synthesi
requir
fix
sequenc
c
terminu
ubl
lack
label
detect
overcom
limit
statsyuk
develop
altern
probe
design
use
dehydroalanin
dha
moieti
place
vinyl
sulfon
trap
catalyt
cy
simplifi
synthesi
preserv
sequenc
ubl
fig
addit
incorpor
alkyn
tag
adenin
moieti
detect
wide
varieti
probe
could
prepar
method
valid
reactiv
probe
toward
relev
enzym
unfortun
probe
cleav
dub
isot
reactiv
probe
toward
ulp
investig
may
limit
applic
studi
dubsulp
present
separ
public
statsyuk
report
abp
enzym
label
substrat
ububl
rather
enzym
probe
refer
fig
take
advantag
revers
transthiol
step
ampub
complex
transfer
ub
catalyt
cy
form
amp
fig
author
design
amp
mimic
would
react
complex
form
stabl
ampub
analog
adenyl
transthiol
step
must
occur
prior
probe
reaction
format
ampub
analog
report
activ
analog
pevonedistat
inhibitor
enzym
nae
current
clinic
trial
fig
differ
pevonedistat
show
reactiv
addit
includ
alkyn
detect
enrich
though
click
reaction
respect
probe
react
varieti
enzym
vitro
presenc
cognat
ububl
protein
atp
significantli
use
character
intracellular
potenc
select
inhibitor
close
analog
select
label
ub
ubl
suggest
select
toward
ub
enzym
unexpect
advantag
probe
linker
form
ububl
probe
cleav
acid
condit
facilit
subsequ
proteom
studi
protein
elut
rel
mild
condit
affin
purif
reduc
background
nonspecif
bound
protein
probe
describ
use
studi
activ
enzym
howev
enzym
also
involv
second
process
transfer
ub
enzym
stanley
et
al
develop
abp
profil
transthiol
reaction
consist
enzym
tag
electrophil
catalyt
cy
probe
undergo
reaction
catalyt
cy
activ
enzym
fig
probe
deriv
select
label
cell
lysat
could
use
competit
abpp
experi
test
inhibitor
perhap
surprisingli
probe
label
author
suggest
ub
requir
induc
conform
inde
author
subsequ
report
probe
contain
ub
moieti
rbr
ligas
abp
discuss
although
major
ligas
form
coval
intermedi
ub
hect
rbr
famili
accept
ub
enzym
transthiol
reaction
subsequ
transfer
substrat
aminolysi
step
coval
natur
intermedi
make
hect
rbr
suitabl
candid
develop
abp
recent
first
abp
transthiol
step
describ
build
probe
transthiol
describ
probe
activ
site
modifi
trap
cognat
enzym
react
addit
requir
ub
activ
enzym
transthiol
pao
et
al
extend
probe
ub
moieti
gener
conjug
intern
electrophil
fig
eas
detect
enzym
could
prepar
epitop
tag
alkyn
tag
allow
conjug
fluorophor
rapid
detect
label
speci
fluoresc
probe
label
ligas
parkin
member
rbr
famili
encod
gene
mutat
form
parkinson
diseas
pd
author
test
transthiol
activ
recombin
parkin
mutant
deriv
patient
pd
found
mutant
test
reduc
transthiol
activ
probe
also
use
investig
parkin
activ
cell
mitochondri
depolar
activ
kinas
encod
turn
activ
parkin
cell
deriv
pd
patient
mutat
chemic
induct
mitochondri
depolar
activ
parkin
detect
probe
label
contrast
activ
observ
cell
number
sampl
test
small
observ
suggest
possibl
use
probe
diagnos
famili
form
pd
pathway
mutat
anticip
ligas
probe
describ
pao
et
al
find
applic
beyond
detail
dissect
singl
interact
exampl
probe
could
use
identifi
novel
interact
given
could
use
competit
abpp
experi
identifi
inhibitor
activ
transthiol
increas
sophist
techniqu
produc
modifi
fusion
protein
introduc
reactiv
function
expect
new
method
studi
enzym
emerg
next
year
deubiquitinas
abp
enzym
one
hect
ligas
reaction
shown
occur
cy
residu
probe
use
infer
reactiv
hect
clearli
probe
optim
studi
multipl
type
enzym
up
simultan
mulder
et
al
recent
publish
eleg
method
target
enzym
singl
abp
probe
fig
activ
enzym
manner
ub
pass
sequenti
along
enzym
transthiol
step
probe
also
option
react
irrevers
activ
site
cy
importantli
probe
becom
conjug
target
protein
appear
rather
unreact
toward
dub
probe
could
label
fluorophor
biotin
latter
use
enrich
label
protein
profil
ub
conjug
machineri
tandem
ms
author
also
deliv
probe
cell
electropor
potenti
overcom
limit
perform
label
experi
lysat
disrupt
intracellular
structur
dilut
cytosol
may
well
reduc
abil
probe
rapidli
label
mani
protein
ub
conjug
machineri
exist
extens
toolbox
abp
dub
abp
enzym
recent
report
nevertheless
sever
challeng
remain
cell
permeabl
abp
dub
probe
ub
conjug
machineri
studi
proteasom
shown
substanti
differ
label
lysat
label
live
cell
dub
abp
would
open
substanti
new
opportun
includ
excit
possibl
studi
activ
enzym
live
organ
ward
et
al
recent
report
abp
usp
dub
modifi
coval
dub
inhibitor
approach
could
extend
attach
report
tag
inhibitor
select
dub
probe
dub
probe
extrem
use
abpp
experi
select
probe
would
use
studi
singl
enzym
small
subset
enzym
exampl
examin
pharmacodynam
dub
inhibitor
dub
probe
like
increas
sensit
deconvolut
individu
protein
becom
unnecessari
select
small
molecul
engin
ub
variant
could
provid
suitabl
recognit
probe
increas
interest
chain
correspond
deubiquitinas
import
role
inflamm
abp
dub
would
valuabl
tool
studi
physiolog
intrigu
linkageprob
jammmpn
dub
jammmpn
famili
dub
metalloproteas
form
coval
intermedi
substrat
therefor
challeng
develop
abp
becom
coval
attach
enzym
sever
group
report
strategi
develop
abp
metalloproteas
cravatt
incorpor
photocrosslink
alkyn
tag
inhibitor
introduc
cy
residu
protein
interest
could
react
electrophil
probe
similar
strategi
could
appli
develop
coval
abp
jammmpn
probe
asid
cascad
abp
report
mulder
et
al
abp
enzym
probe
transthiol
activ
enzym
describ
fig
analog
probe
base
enzym
may
use
studi
transthiol
activ
modif
ub
recent
studi
shown
ub
modifi
phosphoryl
acetyl
signific
biolog
consequ
review
howev
mechan
modif
affect
function
ub
poorli
understood
synthet
semisynthet
method
produc
homogen
modifi
ub
ub
chain
report
yet
appli
abp
probe
ub
conjug
deconjug
machineri
incorpor
defin
modif
could
provid
insight
modif
ub
affect
function
ubiquitin
versatil
process
correspondingli
versatil
techniqu
requir
studi
abp
physic
coupl
protein
probe
reaction
especi
suit
studi
ubiquitin
deubiquitin
enzym
recogn
featur
share
enzym
eg
nucleophil
cy
residu
site
close
catalyt
center
featur
differ
eg
number
site
probe
develop
interrog
specif
compon
ubiquitinationdeubiquitin
system
new
probe
doubt
continu
emerg
inspir
innov
method
protein
chemistri
fascin
biolog
clinic
import
ubiquitin
modif
